Logo
SearchSearch
Languages
Language
LoginSign up
Invest in Revance Therapeutics Inc
Today
Create an eToro account to buy RVNC stock on a secure, user-friendly, multi-asset trading platform.
Buy Revance Therapeutics Inc
RVNC Price
Revance Therapeutics Inc RVNC
RVNC Price

Revance Therapeutics Inc RVNC

$3.080.01(0.33%)(1D)

RVNC Stock Price Chart

-23.44%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset stable trend

The Revance Therapeutics Inc share price is stable this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Revance Therapeutics Inc share price today is 3.08, reflecting a 0.33% change over the last 24 hours and -0.33% over the past week. The current market capitalization of RVNC is 321.52M with an average volume in the last three months of 2.52M. The stock has a P/E ratio of -1.6 and a dividend yield of 0%. With the stock’s beta sitting at 1.32
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$321.52M

Day’s Range
i
Shows the high and low prices of the day.
3.01 - 3.79

52W Range
i
Shows the high and low prices of the last year.
2.26 - 32.18

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
2.52M

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-1.6

Revenue
i
The total income generated by this company’s goods and services last year.
$247M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
$3.08

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-1.92

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.32

What Is Revance Therapeutics Inc?
Revance Therapeutics is a healthcare company based in Newark, California and listed on the NASDAQ GM under the ticker RVNC. Founded in 1999, the company operates globally, working on the creation of neuromodulators and covering the whole supply process. To see the RVNC price chart, add Revance Therapeutics to your watchlist.

How can I buy Revance Therapeutics Inc stocks?

To purchase Revance Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Revance Therapeutics Inc (RVNC) page and place an order to buy Revance Therapeutics Inc.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Graph
Buy Revance Therapeutics Inc
Invest in Revance Therapeutics Inc
Today
Create an eToro account to buy RVNC stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of RVNC is 3.08.
The average price target for Revance Therapeutics Inc is 3.08. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Revance Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Revance Therapeutics Inc is 321.52M
Scroll to top